ALB and cancer: The nanoparticle albumin-bound strategy has allowed the creation of some effective anti-cancer nanoparticle drugs that are available on the market, like Abraxane nab-paclitaxel developed by Abraxis BioScience and Fyarro nab-sirolimus developed by Aadi Bioscience.